Doozio Posted - 1 day ago

$AVIR if no faatch 💣 lands can it GOTU ELYM too during 🧠⏰♾️???

Doozio Posted - 4 days ago

$AVIR ghetto banging outta da tightness bahhhtom of da base in 🧠⏰♾️

Covid_Sucks Posted - 04/30/24

$AVIR https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html

DonCorleone77 Posted - 04/29/24

$AVIR Atea Pharmaceuticals announces presentation on safety profile of bemnifosbuvir Atea Pharmaceuticals announced the presentation of Phase 1 data highlighting the safety profile of bemnifosbuvir, an oral nucleotide polymerase inhibitor, at the European Society of Clinical Microbiology & Infectious Diseases Global 2024, which is taking place April 27-30, 2024 in Barcelona, Spain. "The results presented at ESCMID further support the favorable safety profile for bemnifosbuvir by demonstrating the lack of cardiotoxicity in healthy participants," said Jean-Pierre Sommadossi, PhD, Chief Executive Officer and Founder of Atea Pharmaceuticals. "Our goal is to address the substantial unmet need for the treatment of COVID-19 and hepatitis C virus (HCV), which continues due to the limitations of available treatments. During the second half of 2024, we look forward to reporting results for bemnifosbuvir from our Phase 3 SUNRISE-3 trial for COVID-19 and results for the combination of bemnifosbuvir and ruzasvir from our Phase 2 trial for HCV."

Stock_Titan Posted - 04/29/24

$AVIR Atea Announces Presentation of Data Highlighting Favorable Safety Profile of Bemnifosbuvir at ESCMID Global 2024 https://www.stocktitan.net/news/AVIR/atea-announces-presentation-of-data-highlighting-favorable-safety-9m6mmcez21zm.html

Covid_Sucks Posted - 04/07/24

$AVIR “We found that long COVID can affect nearly every organ system. We looked at the heart, the lungs, we looked at the kidneys, we saw increased risk of diabetes, mental health disorders, blood clotting problems, we saw increased risk for nearly every organ system. Long COVID is non-monolithic. It’s very heterogeneous and can present in multiple different ways. Even if people dodged the bullet the first time and did not get long COVID, re-infection can contribute additional risks of long COVID. Dr Ziyad Al-Aly Chief of research and development at VA Saint Louis Health Care System and senior clinical epidemiologist for the Institute for Public Health at Washington University School of Medicine

Covid_Sucks Posted - 04/07/24

$AVIR COVID-19 Leaves Its Mark on the Brain. Significant Drops in IQ Scores Are Noted Research shows that even mild COVID-19 can lead to the equivalent of seven years of brain aging MARCH 13, 2024, Scientific American https://www.scientificamerican.com/article/covid-19-leaves-its-mark-on-the-brain-significant-drops-in-iq-scores-are/

Covid_Sucks Posted - 04/07/24

$AVIR "We found that long COVID can affect nearly every organ system. We looked at the heart, the lungs, we looked at the kidneys, we saw increased risk of diabetes, mental health disorders, blood clotting problems, we saw increased risk for nearly every organ system. Long COVID is non-monolithic. It’s very heterogeneous and can present in multiple different ways. Even if people dodged the bullet the first time and did not get long COVID, re-infection can contribute additional risks of long COVID." Dr. Ziyad Al-Aly Chief of research and development at VA Saint Louis Health Care System and senior clinical epidemiologist for the Institute for Public Health at Washington University School of Medicine

commoncentsinvestor Posted - 1 month ago

$AVIR SMALL CAP INVESTORS Anyone looking for a stock that could have a big increase in share price in 2024 might want to take a look at CVRX. They got FDA approval for its Barostim product to improve the lives of people suffering from heart failure back in 2019. They have spent the last 4 years building a market for their product and it is about to reap big rewards. They have been increasing their revenues, the number of implant centers, their territories, , and their public visibility by leaps and bounds and work on 84% gross margins. This should all result in big increases in revenues and share price this year. I expect a minimum of $65M in 2024 revenues and with 84% Gross Margins, a 15 times Market Cap would be very reasonable. That would put the share price at about $47. Current Share Price is under $18. With only 600 followers on Stock Twits, it is very early in the game for folks who like to invest in under followed small companies with HUGE potential.

Covid_Sucks Posted - 03/27/24

$AVIR If these guys can demonstrate that AT-527 mitigated the development of long covid, this stuff is dynamite.

Covid_Sucks Posted - 03/27/24

$AVIR Dr Al-Aly testifying before the U.S. Senate Committee on Health, Education, Labor and Pensions Jan 2024 https://twitter.com/i/status/1748037164913267006

Covid_Sucks Posted - 03/27/24

$AVIR from today's press release: "Secondary endpoints include other measurements of patient outcomes through Day 60 post-treatment." Heart attacks, strokes, arrhythmias, peripheral vascular disease, aortic dissections, etc. How many of the "long covid" types of pathology might they find were decreased by AT-527 ???? They may discover all kinds of things are post covid associated that we currently don't appreciate. How's this for a headline: "If you get covid, take Bemnifosbuvir and you'll be less likely to have a heart attack." Paxlovid doesn't have anything close to that, and our guys are looking into it. I'm really looking forward to the results of their careful analysis of the "All Cause Hospitalization" data. We really don't have a good appreciation of "Long Covid" and acute treatment with an antiviral may, just may, Prevent It. Vasculitis. Look at Ziyad Al-Aly's data.

Stock_Titan Posted - 03/27/24

$AVIR Atea Pharmaceuticals Completes Patient Enrollment in Global Phase 3 SUNRISE-3 Trial Evaluating Oral Antiviral Bemnifosbuvir for COVID-19 in High-Risk Patients https://www.stocktitan.net/news/AVIR/atea-pharmaceuticals-completes-patient-enrollment-in-global-phase-3-tewc1494sc2z.html

SorosSonosSatoshi Posted - 2 months ago

$AVIR 3.333 game over mode., 3.666 flash crash razors 3.33 down to 3.0666 Who agrees?

fda_tracker Posted - 2 months ago

$AVIR Phase 3 trial w/est Mar completion date NCT05629962: https://www.clinicaltrials.gov/study/NCT05629962 Trial Tracker: https://www.fdatracker.com/trial-tracker/

epsguid Posted - 02/28/24

$AVIR reported a loss of $0.47, consensus was ($0.44) via @eWhispers #epsmiss http://eps.sh/d/avir

Stock_Titan Posted - 02/28/24

$AVIR Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update https://www.stocktitan.net/news/AVIR/atea-pharmaceuticals-reports-fourth-quarter-and-full-year-2023-6xxgasdd4dai.html

anonapplicable Posted - 02/27/24

$AVIR what’s going onnnnn

Wisenheimer Posted - 02/27/24

$AVIR watch for a multi yr breakout - last yr their was an offer to buy co at $5.75 - co has $7.00 in cash per share no debt. Should trade north of there

fnasrallah Posted - 02/21/24

$AVIR the big vaccine study that came out should help with AVIR.

Stock_Titan Posted - 02/21/24

$AVIR Atea Pharmaceuticals to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call on February 28, 2024 https://www.stocktitan.net/news/AVIR/atea-pharmaceuticals-to-host-fourth-quarter-and-full-year-2023-y4f5c5r8i79l.html

swingingtech Posted - 02/15/24

$CROX, $GEO, $AVIR https://wallstreetwaves.com/noteworthy-thursday-option-activity-crox-geo-avir/

Wisenheimer Posted - 02/15/24

$AVIR selling LOL - insiders are holding onto their shares the “sale” is just to offset their tax obligation net net their increasing their position - $595mm in cash ($7.00) and no debt! See u at $10.00

analysis_first Posted - 02/15/24

$VNDA VNDA is the only pharma trading below net cash with meaningful commercial products, revenue ($150-200mm run-rate), and pipeline. If legacy VNDA worth just 2x rev (or $350mm) plus $100mm for Ponvory plus $400mm cash, VNDA market cap could be $850mm, or $15/shr. And that's with no value to pipeline. Need this Kevin Tang to light a match under management to cut costs and buyback stock or sell to eliminate them. He should add VNDA to $AVIR and $DTIL net cash plays. Am I wrong?

IDontBelieveYou Posted - 02/12/24

$AVIR classic short setup

Doozio Posted - 02/08/24

$AVIR chop chop huckleberries. 🧠⏰

insiderbuyingselling Posted - 3 months ago

$AVIR new insider selling: 15870 shares. http://insiderbuyingselling.com/?t=AVIR

insiderbuyingselling Posted - 3 months ago

$AVIR new insider selling: 12477 shares. http://insiderbuyingselling.com/?t=AVIR

Wisenheimer Posted - 3 months ago

$AVIR i kind of like failure = less spend and may get closer to cash - either way I think positive in a backwards kind of way

BabyGangsterAX Posted - 01/31/24

$AVIR I think phase 3 will fail. Becareful guys!